Aurora Cannabis has launched the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's EU-GMP facility in Leuna, Germany, the new brand offers a supply of locally grown and sold, medical cannabis for the country's patient base.
"Aurora is proud to deliver to the rapidly growing German market our first domestically produced medical cannabis product – a significant step forward since Germany's move to decriminalize cannabis earlier this year," says Michael Simon, President, Aurora Europe (Interim).
The main product launched from the IndiMed brand is Island Sweet Skunk, dried flower, sativa, 20% THC, <1 % CBD. Product is expected to be available on January 27. IndiMed is cultivated under GACP and EU-GMP guidelines to ensure pharmaceutical-grade quality. The flowers are harvested by hand, dried under controlled conditions, and tested for purity and active ingredient content.
For more information:
Aurora
auroramj.com